Saltar al contenido
Merck

C5VP001A

Millipore

Cellicon® Filter Assembly with Durapore® Membrane

filtration area 0.01 m2

Sinónimos:

Cellicon® Perfusion Filter with Durapore® Membrane

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización


About This Item

UNSPSC Code:
42294704

material

PET support
PVDF
polyester support

Quality Level

agency

meets USP Biological Reactivity Test for class VI plastics (family component materials)

sterility

sterile; γ-irradiated (level of 25-40kGy)

flow rate measuring range

10 L/min (/m2)

parameter

1 psi max. reverse press. exposure at 25 °C
1-2.5 L process volume
15 psi at 25 °C (max. burst pressure)
5 psi max. inlet pressure at 25 °C

filtration area

0.01 m2

membrane filtration area

0.01 m2

pore size

5 μm pore size

storage temp.

15-25°C

¿Está buscando productos similares? Visita Guía de comparación de productos

General description

Housing/Overmold/ Assembly fittings/Single-use pump head: Polypropylene; Feed screen: Polyethylene terephthalate (PET); Polyester; Tubing: AdvantaFlex (Thermoplastic Elastomer), DOW Pharma 65; Feed screen: Polyethylene terephthalate (PET); Polyester; Pressure sensors: Polysulfone; Cable ties: Nylon
The Cellicon® Perfusion Filter is designed to meet your perfused seed train challenges. It is a flat sheet cell retention filter running in tangential flow filtration mode part of a single-use assembly. Perfusion operations deliver high-density cell cultures that alleviate the burden of processing large production bioreactor volumes while increasing manufacturing flexibility. Introducing perfusion to your seed train makes it possible to inoculate a higher quantity of cells for one or more production bioreactors, thus increasing process efficiency.

Application

Microfiltration
Seed Train Perfusion

Features and Benefits

High throughput. Predictable linear scale up from lab to manufacturing scale. Reliable and reproducible performance. Low crossflow and cell shear.

Other Notes

These products are manufactured in a facility which adheres to Good Manufacturing Practices.

Legal Information

CELLICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Durapore is a registered trademark of Merck KGaA, Darmstadt, Germany

consumable

Referencia del producto
Descripción
Precios

equipment

Referencia del producto
Descripción
Precios

Certificados de análisis (COA)

Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Artículos

This page describes the design attributes of the Cellicon® filter assembly for cell retention and how they simplify scale-up of intensified upstream processes.

This page describes the financial and operational advantages offered by the Cellicon® Cell Retention Device in an N-1 perfusion process at the 2,000 L scale in comparison to a cell retention device from another supplier.

How the Cellicon® filter and controller enables seamless adoption of a perfused N-1 seed train step into the cell expansion process.

Before adoption of single-use technologies in biomanufacturing, manufacturers must assess the risk to the drug product from potential leachables. This article highlights a general approach based on the United States Pharmacopeia (USP).

Ver todo

Contenido relacionado

Enhance perfused seed train efficiency with our cell retention solution. Real-time monitoring and control.

Los desarrolladores biofarmacéuticos necesitan procesos eficientes y productivos en las fases iniciales que proporcionen anticuerpos monoclonales de alta calidad (AcM) y otros tipos de proteínas recombinantes. La intensificación de los procesos puede preparar sus estrategias de fabricación para el futuro, reducir los costes y aumentar la flexibilidad de las instalaciones.

Biopharmaceutical developers need efficient, productive upstream processes that deliver high quality monoclonal antibodies (mAbs) and other types of recombinant proteins. La intensificación de los procesos puede preparar sus estrategias de fabricación para el futuro, reducir los costes y aumentar la flexibilidad de las instalaciones.

Biopharmaceutical developers need efficient, productive upstream processes that deliver high quality monoclonal antibodies (mAbs) and other types of recombinant proteins. Process intensification can future-proof their manufacturing strategies, reduce costs, and increase facility flexibility.

Ver todo

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico